ROYAL BANK OF CANADA - PREVAIL THERAPEUTICS INC ownership

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of PREVAIL THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$27,000
+200.0%
1,171
+30.1%
0.00%
Q3 2020$9,000
-35.7%
900
-2.3%
0.00%
Q2 2020$14,000
+16.7%
921
-5.4%
0.00%
Q1 2020$12,000
-47.8%
974
-34.6%
0.00%
Q4 2019$23,0001,4890.00%
Other shareholders
PREVAIL THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Orbimed Advisors 13,822,463$205,955,0002.90%
Avidity Partners Management LP 1,028,800$15,329,0000.98%
Omega Fund Management, LLC 187,538$2,794,0000.76%
Boxer Capital, LLC 1,123,105$16,734,0000.74%
RA Capital Management 2,494,691$37,171,0000.72%
EcoR1 Capital, LLC 367,218$5,472,0000.40%
QVT Financial LP 133,690$1,992,0000.34%
DAFNA Capital Management LLC 75,000$1,118,0000.32%
Woodline Partners LP 329,135$4,904,0000.19%
Virtus ETF Advisers LLC 22,460$335,0000.16%
View complete list of PREVAIL THERAPEUTICS INC shareholders